On Monday, a New Jersey Senate Committee held an hearing to discuss a proposed bill which would legalize possession, home cultivation, and gifting of Psilocybin Mushrooms for adults over 21 years of age. The bill also created a licensed business system to allow access to psychedelics and related services under supervision.
About a year after it was first filed , the Senate Health, Human Services and Senior Citizens Committee heard testimony from both experts and individuals whose lives were directly affected by psychedelics.
Scutari stated in his opening remarks that this proposal addressed an “important topic” that has received national attention, in light of the studies that show the “medical effectiveness and benefits of Psilocybin.”
He added that the committee’s work will “help craft legislation that will eventually make psilocybin legal here in New Jersey.”
He said that he was grateful for the time taken to discuss an important issue for so many New Jerseyans who are struggling with addiction, mental health, and the like. He suggested that the measure could be modified to focus more narrowly on providing a therapeutic regulatory frame work for access to psychedelics.
Frederick Barret was a professor from Johns Hopkins University’s Center for Psychedelics Research and Psilocybin Therapy. He explained how psychedelic therapy works and outlined some initial findings.
Heady NJ first , a -reported , reported that he said there is an expectation that MDMA will be “approved in the next year” from the federal Food and Drug Administration.
Barret stated that “while it may take a long time, and sometimes even too long…I want to respect this process.” “I think criminalizing the possession of compounds such as this will do more harm than good,” Barret said.
At the conclusion of the Hearing, the committee chair, Sen. Joseph Vitale, (D), stated that this “will be a developing issue for us” and “there is a lot to learn before the legislature takes action.” “This has been very educational for the members in this committee.”
The Senate President’s Bill, as it is currently introduced, would create treatment centers for psilocybin therapy where adults over 21 could go to receive this psychedelic therapy.
The measure also makes it legal for adults “to possess, store, use ingest, inhale or process four grams of psilocybin or less, and to deliver, transport or distribute this substance without consideration.”
It is also not illegal for someone over 21 to cultivate or process psilocybin-producing plants or fungi for personal use or to possess psilocybin if they are kept in a private residence or home and kept away from children under 21.
Marijuana Moment tracks more than 1,000 cannabis and psychedelics bills, as well as drug policy legislation in state legislatures. Patreon supporters who pledge at least $25/month gain access to our interactive charts, maps and hearing calendar.
Discover more about our marijuana bills tracker. Become a Patreon supporter to gain access.
—
This is a particularly notable provision because New Jersey’s laws on marijuana do not allow adults, or even medical cannabis patients, to grow their own plants, much the dismay of reform advocates.
This legislation would expand significantly on the legislation that he introduced late in 2020, which was signed by Governor. Phil Murphy (D), in 2021.
According to the measure, “engaging in authorized conduct” will not be a crime under state law, county law, or any municipal law; it won’t constitute a basis for assessing a civil punishment, civil sanction, professional or administrative discipline against anyone; nor will it constitute a basis for the detention, search or arrest of anybody; nor can the measure serve as a basis to deny any person any rights or privileges, or seize or forfeit any assets under state law, county law, or any municipal law,
People who have been convicted of an offense which would become legal under this bill will be able to petition the court for a resentencing, or for expungements.
The bill sets out the basic regulations for the psilocybin service program. This includes licensing requirements. In addition to the psilocybin worker permits, there would be four types of licenses: product manufacturers, service centers operators, testing labs and service facilitators. The State Department of Health would oversee the program and licenses.
The proposed licensing system also includes equity. The “social opportunity program”, which is available to manufacturing, service centers and testing applicants who meet certain criteria (including having more than 10 employees and living in an economically depressed area for at least five years in the last ten), would allow them to apply.
The DOH was tasked to develop the social opportunity program, in coordination with a Psilocybin Behavioral Health Access and Services Advisory Board of 18 members that would be created within the Department.
The members of this board must include the Health Commissioner, the Deputy Commissioner for Public Health Services, and the Attorney General (or their designees). These would be non-voting, ex officio members. The board will also include a representative from the state’s Cannabis Regulatory Commission, and 12 members appointed by the governor with relevant experience.
The text states that “the board will provide advice and make recommendations to the DOH on request or at the board’s initiative regarding the implementation of this bill.” The board would make recommendations on issues like public education, therapeutic research, guidelines for psychedelic service, safety and health standards, and more.
The bill states that local governments can “adopt, by ordinances, reasonable regulations regarding the operation of psilocybin manufacturers and psilocybin services centers located in that county or city.”
It states that “no county or municipality shall be authorized to impose any taxes or fees for the manufacture, sale or provision of psilocybin-containing products or services.”
This is just one example of how legislators across the nation are approaching psychedelics policies this session.
The California Assembly Committee is scheduled to consider a bill that was passed by the Senate to legalize possession and facilitate use of certain psychedelics on Tuesday. The sponsor recently warned that it faces a “challenging path” before it.
Last month, the governor of Minnesota approved a bill with similar provisions that would establish a task force to study psychedelics and prepare Minnesota for possible legalization.
Colorado Gov. Jared Polis, a Democrat, signed a law last month that created a regulatory framework to legal psychedelics as part of a voter-approved measure. Last week, he also discussed his desire for the legislature to authorize him to pardon psychedelic-related convictions.
A North Carolina House Committee approved a bill last month to create a grant program of $5 million to support research on the potential therapeutic benefits of psilocybin, and to create a Breakthrough Therapies Research Advisory Board.
The governor also signed a bill in Washington State to encourage research into psilocybin, and to create a program that would provide access to psychedelics for mental health treatments.
In New Jersey, last month , the governor signed into law a bill which will allow licensed marijuana business to deduct some expenses on their state taxes. This is a partial solution as the industry has been blocked from federal deductions due to the Internal Revenue Service code 280E.
Florida Attorney-General Argues Marijuana Legitimation Ballot Measure Is Misleading Voters in Brief to Supreme Court
The article New Jersey senators discuss top lawmaker’s psilocybin legalization bill in committee first appeared on Marijuana Moment.
